(Q36337922)

13 August 2017

1 reference

title

Prospects of RNA interference therapy for cancer (English)

1 reference

13 August 2017

1 reference

Pai SI

1

1 reference

13 August 2017

Lin YY

2

1 reference

13 August 2017

Macaes B

3

1 reference

13 August 2017

Meneshian A

4

1 reference

13 August 2017

Hung CF

5

1 reference

13 August 2017

Wu TC

6

1 reference

13 August 2017

publication date

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

13

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

464-477

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302694

13 August 2017

exact match

0 references

cites work

Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

siRNAs: applications in functional genomics and potential as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

The prospect of silencing disease using RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Targeted mRNA degradation by double-stranded RNA in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

A species of small antisense RNA in posttranscriptional gene silencing in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

siRNA as a route to new cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

RNA interference: from gene silencing to gene-specific therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

RET signals through focal adhesion kinase in medullary thyroid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

B-RAF is a therapeutic target in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Polymerase synthesis and potential interference of a small-interfering RNA targeting hPim-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Transcriptional regulation by a DNA-associated form of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

AKT involvement in cisplatin chemoresistance of human uterine cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

An approach to genomewide screens of expressed small interfering RNAs in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by e6 siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Antisense to apoptosis inhibitors facilitates chemotherapy and TRAIL-induced death signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Survivin splice variants regulate the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Enhancement of C2-ceramide antitumor activity by small interfering RNA on X chromosome-linked inhibitor of apoptosis protein in resistant human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Regulation of cellular senescence and p16(INK4a) expression by Id1 and E47 proteins in human diploid fibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Senescence-initiated reversal of drug resistance: specific role of cathepsin L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

A census of human cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Oncogenic kinase signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

The p53 pathway: positive and negative feedback loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Functional characterization of hepatoma-specific stem cell antigen-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Angiogenesis: regulators and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Use of RNA interference to inhibit integrin (alpha6beta4)-mediated invasion and migration of breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

siRNA agents inhibit oncogene expression and attenuate human tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

IDO and tolerance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Cancer therapeutics: personal experiences and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

siRNA therapeutics: big potential from small RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Gene silencing in androgen-responsive prostate cancer cells from the tissue-specific prostate-specific antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Virus-based reporter systems for monitoring transcriptional activity of hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Activation of the interferon system by short-interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Mechanistic insights aid computational short interfering RNA design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Induction of an interferon response by RNAi vectors in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Noise amidst the silence: off-target effects of siRNAs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

inferred from DOI database lookup

7 January 2021

based on heuristic

Pro-angiogenic signaling by the endothelial presence of CEACAM1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

inferred from DOI database lookup

7 January 2021

based on heuristic

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302694

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302694

1 reference

Dimensions Publication ID

13 August 2017

1031622231

0 references

1 reference